[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-335889-105":59,"doc-detail-335889-en":122},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":115,"head_meta":117,"extra_data":119,"updated_unix":121},105,"en","exploration-of-oxidized-phosphocholine-profile-in-non-small-cell-lung-cancer","Exploration of oxidized phosphocholine profile in non-small-cell lung cancer","","Exploration of oxidized phosphocholine (oxPC) profiles in non-small-cell lung cancer (NSCLC) investigates how oxidized phospholipids relate to tumor biology and inflammation. The study quantifies oxPC levels in nearly 350 plasma and lung tissue samples from 200 NSCLC patients, including adenocarcinoma and squamous cell carcinoma, with COPD patients as controls. Results show long-chain oxPC predominance in plasma and short-chain oxPC enrichment in tissues, with the highest concentrations in central tumor regions and higher oxPC levels in adenocarcinoma versus controls and squamous cell carcinoma.",{"@graph":69,"@context":114},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/exploration-of-oxidized-phosphocholine-profile-in-non-small-cell-lung-cancer/335889/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/exploration-of-oxidized-phosphocholine-profile-in-non-small-cell-lung-cancer/335889.png","ImageObject",300,407,{"name":92,"@type":93},"Logic","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108],{"name":109,"@type":110,"acceptedAnswer":111},"What oxPC pattern differences were observed between plasma and tissue?","Question",{"text":112,"@type":113},"Long-chain oxPCs predominated in plasma samples, while short-chain oxPCs were enriched in tissue samples from NSCLC patients, with the highest concentrations in the central tumor region.","Answer","https://schema.org",{"og:url":83,"og:type":116,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":118,"canonical":83},"index,follow",{"doc_id":120,"site_id":62},335889,1790071601,{"code":4,"msg":5,"data":123},{"doc_id":120,"user_id":124,"nickname":92,"user_avatar":125,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":126,"file_id":127,"file_url":128,"file_type":129,"file_size":130,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":131,"language":132,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":133,"faqs":134,"seo_title":135,"seo_description":67,"update_tm":136,"read_time":36,"preview_page_count":4},1099513958762,"https://ap-avatar.wpscdn.com/avatar/1000023916a998db790?x-image-process=image/resize,m_fixed,w_180,h_180&k=1784791008015729253","TYPE Original Research PUBLISHED 15 January 2024  \nDOI 10.3389/fmolb.2023.1279645  \nOPEN ACCESS  \nEDITED BY  \nVíctor González-Ruiz,  \nUniversity of Geneva, Switzerland  \nREVIEWED BY  \nTania C. B. Santos,  \nWeizmann Institute of Science, Israel Alessia Ferrarini,  \nSpanish National Centre for Cardiovascular Research, Spain  \nIsabel Meister,  \nUniversity of Geneva, Switzerland  \n*CORRESPONDENCE  \nMichal Ciborowski,  \n [michal.ciborowski@umb.edu.pl](michal.ciborowski@umb.edu.pl)  \nRECEIVED 18 August 2023  \nACCEPTED 20 December 2023  \nPUBLISHED 15 January 2024  \nCITATION  \nGodzien J, Lopez-Lopez A, Sieminska J, Jablonowski K, Pietrowska K, Kisluk J, Mojsak M, Dzieciol-Anikiej Z, Barbas C, Reszec J, Kozlowski M, Moniuszko M, Kretowski A, Niklinski J and Ciborowski M (2024), Exploration of oxidized phosphocholine proﬁle in nonsmall-cell lung cancer.  \nFront. Mol. Biosci. 10:1279645 .  \ndoi: 10.3389/fmolb.2023.1279645  \nCOPYRIGHT  \n© 2024 Godzien, Lopez-Lopez, Sieminska, Jablonowski, Pietrowska, Kisluk, Mojsak, Dzieciol-Anikiej, Barbas, Reszec, Kozlowski, Moniuszko, Kretowski, Niklinski and Ciborowski. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nExploration of oxidized phosphocholine proﬁle in non-small-cell lung cancer  \nJoanna Godzien 1, Angeles Lopez-Lopez 2, Julia Sieminska 1, Kacper Jablonowski 1, Karolina Pietrowska 1, Joanna Kisluk 3, Malgorzata Mojsak 4, Zoﬁa Dzieciol-Anikiej5, Coral Barbas 2, Joanna Reszec 6, Miroslaw Kozlowski 7, Marcin Moniuszko 8, Adam Kretowski 1, Jacek Niklinski 3 and Michal Ciborowski 1*  \n1Metabolomics Laboratory, Clinical Research Centre, Medical University of Bialystok, Bialystok, Poland, 2Centro de Metabolómica y Bioanálisis (CEMBIO), Facultad de Farmacia, Universidad San Pablo-CEU, CEU Universities, Boadilla del Monte, Spain, 3Department of Clinical Molecular Biology, Medical University of Bialystok, Bialystok, Poland, 4Independent Laboratory of Molecular Imaging, Medical University of Bialystok, Bialystok, Poland, 5Department of Rehabilitation, Medical University of Bialystok, Bialystok, Poland, 6Department of Medical Pathomorphology, Medical University of Bialystok, Bialystok, Poland, 7Department of Thoracic Surgery, Medical University of Bialystok, Bialystok, Poland, 8Department of Regenerative Medicine and Immune Regulation, Medical University of Bialystok, Bialystok, Poland  \nIntroduction: Lung cancer is one of the most frequently studied types of cancer and represents the most common and lethal neoplasm. Our previous research on non-small cell lung cancer (NSCLC) has revealed deep lipid proﬁle reprogramming and redox status disruption in cancer patients. Lung cell membranes are rich in phospholipids that are susceptible to oxidation, leading to the formation of bioactive oxidized phosphatidylcholines (oxPCs) . Persistent and elevated levels of oxPCs have been shown to induce chronic inﬂammation, leading to detrimental effects. However, recent reports suggest that certain oxPCs possess anti-inﬂammatory, pro-survival, and endothelial barrierprotective properties. Thus, we aimed to measure the levels of oxPCs in NSCLC patients and investigate their potential role in lung cancer.  \nMethods: To explore the oxPCs proﬁles in lung cancer, we performed in-depth, multi-level metabolomic analyses of nearly 350 plasma and lung tissue samples from 200 patients with NSCLC, including adenocarcinoma (ADC) and squamous cell carcinoma (SCC), the two most prevalent NSCLC subtypes and COPD patients as a control group. First, we performed oxPC proﬁling of plasma samples. Second, we analyzed tumor and non-cancero","cbCaiq934Pm5WdIK","https://ap.wps.com/l/cbCaiq934Pm5WdIK","pdf",1908591,16,"English","# Introduction\n# Methods\n# Results\n# Conclusion","[{\"question\":\"What oxPC pattern differences were observed between plasma and tissue?\",\"answer\":\"Long-chain oxPCs predominated in plasma samples, while short-chain oxPCs were enriched in tissue samples from NSCLC patients, with the highest concentrations in the central tumor region.\"}]","Exploration of oxidized phosphocholine profile in non-small-cell lung cancer | PDF",1790012746]